Toxin peptides targeting acid-sensing ion channels: Opportunities for cancer diagnosis and therapy

Romain Baudat1, Sylvie Diochot2, Laura Lange1

  • 1Université Paris-Saclay, CEA, Département Médicaments et Technologies pour la Santé (DMTS), Service d'Ingénierie Moléculaire pour la Santé (SIMoS), EMR CNRS 9004, Gif-sur-Yvette F-91191, France.

Insights

Acid-sensing ion channels (ASICs) are crucial for nervous system function and implicated in diseases like cancer. Toxin peptides offer precise tools for studying ASICs and developing new diagnostic and therapeutic strategies.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Oncology

Background:

  • Acid-sensing ion channels (ASICs) are proton-gated cation channels vital for neuronal excitability, synaptic plasticity, and pain perception.
  • ASICs are implicated in pathologies like cancer due to their role in pH regulation and ion balance within acidic microenvironments.

Purpose of the Study:

  • To review the physiological and pathological roles of ASICs.
  • To examine the contribution of toxin peptides to ASIC research.
  • To discuss the translational potential of ASIC modulation in biomedical imaging and targeted therapies, especially for cancer.

Main Methods:

  • Literature review focusing on ASIC physiology, pathology, and toxin peptide interactions.
  • Analysis of current research on ASIC structure-function relationships.
  • Exploration of theranostic applications of ASIC-targeting toxins.

Main Results:

  • ASICs are key regulators of neuronal function and are dysregulated in various diseases.
  • Toxin peptides serve as highly selective molecular probes for ASICs, offering insights into their mechanisms.
  • ASIC-targeting toxins show promise for diagnostic imaging and targeted cancer therapies.

Conclusions:

  • ASICs play significant roles in both normal physiology and disease states.
  • Toxin peptides are invaluable tools for advancing ASIC research and therapeutic development.
  • Modulation of ASICs holds considerable translational potential for theranostic applications in oncology and beyond.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
663
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K